Safety and immunogenicity of a killed oral cholera vaccne among infants aged 10 weeks to less than 12 months of Age when given concomitantly with EPI vaccines.

Trial Profile

Safety and immunogenicity of a killed oral cholera vaccne among infants aged 10 weeks to less than 12 months of Age when given concomitantly with EPI vaccines.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 May 2017

At a glance

  • Drugs Cholera vaccine (Primary) ; Diphtheria tetanus and pertussis vaccine; Hepatitis B vaccine recombinant; Measles virus vaccine live; Poliovirus vaccine
  • Indications Cholera; Diphtheria; Hepatitis B; Measles; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 01 May 2015 Planned primary completion date changed from 1 Jan 2014 to 1 Aug 2016 as reported by ClinicalTrials.gov record.
    • 01 May 2015 Planned initiation date changed from 1 Feb 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
    • 01 May 2015 Planned End Date changed from 1 Jan 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top